Konrad C, Schormair C, Eikelmann B, Telger K
Westf. Klinik für Psychiatrie und Psychotherapie, Münster.
Psychiatr Prax. 1997 Mar;24(2):88-9.
Recently, American authors pronounced the hypothesis that Clozapine-response may be considered as a predictor of response to atypical neuroleptic. We report the history of a schizoaffektive patient unresponsive to butyrophenone and phenothiazine neuroleptic who was first treated with Clozapine and then with Risperidone and who reacted very differently to these atypical neuroleptic.
最近,美国作者提出一种假说,即氯氮平反应可被视为对非典型抗精神病药物反应的预测指标。我们报告了一名分裂情感性障碍患者的病史,该患者对丁酰苯类和吩噻嗪类抗精神病药物无反应,最初接受氯氮平治疗,随后接受利培酮治疗,且对这些非典型抗精神病药物反应差异很大。